Who Paid My Doc
Open-label external control arm study of darolutamide plus A
Research payments
$5,124,435
Through program year 2025, $5,124,435 in research payments was reported against Open-label external control arm study of darolutamide plus A, across 3,501 payments, paid by Bayer HealthCare Pharmaceuticals Inc..
- Paid by
- Bayer HealthCare Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $21,489 | 16 |
| 2024 | Research | $81,441 | 45 |
| 2023 | Research | $4,391,338 | 3,155 |
| 2022 | Research | $630,168 | 285 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Joelle Hamilton Homewood, AL Named on 457 payments
- Phoebe Cheng Ann Arbor, MI Named on 312 payments
- Ashley Ross Chicago, IL Named on 307 payments
- Jeanny Aragon-Ching Falls Church, VA Named on 302 payments
- Marc Pliskin Cincinnati, OH Named on 291 payments
- Gordon Brown Cherry Hill, NJ Named on 267 payments
- Hilary Ma Houston, TX Named on 228 payments
- Elisabeth Heath Detroit, MI Named on 182 payments
- Edward Uchio Orange, CA Named on 142 payments
- Raymond Lance Spokane, WA Named on 133 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.